BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 12873797)

  • 1. The hypocretin/orexin system in health and disease.
    Nishino S
    Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
    Chemelli RM; Willie JT; Sinton CM; Elmquist JK; Scammell T; Lee C; Richardson JA; Williams SC; Xiong Y; Kisanuki Y; Fitch TE; Nakazato M; Hammer RE; Saper CB; Yanagisawa M
    Cell; 1999 Aug; 98(4):437-51. PubMed ID: 10481909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
    Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
    Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors.
    Mieda M; Yanagisawa M
    Curr Opin Neurobiol; 2002 Jun; 12(3):339-45. PubMed ID: 12049942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narcolepsy: a key role for hypocretins (orexins).
    Siegel JM
    Cell; 1999 Aug; 98(4):409-12. PubMed ID: 10481905
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of hypocretins (orexins) in sleep regulation and narcolepsy.
    Taheri S; Zeitzer JM; Mignot E
    Annu Rev Neurosci; 2002; 25():283-313. PubMed ID: 12052911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Involvement of orexins/hypocretins in multiple physiological functions].
    Ueta Y
    J UOEH; 2001 Jun; 23(2):147-59. PubMed ID: 11431960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocretin administration as a treatment for human narcolepsy.
    Siegel JM
    Sleep; 2003 Dec; 26(8):932-3. PubMed ID: 14746368
    [No Abstract]   [Full Text] [Related]  

  • 10. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
    Beuckmann CT; Yanagisawa M
    J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
    Nishino S
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1785-97. PubMed ID: 17970638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog.
    Fujiki N; Yoshida Y; Ripley B; Mignot E; Nishino S
    Sleep; 2003 Dec; 26(8):953-9. PubMed ID: 14746374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretin/orexin: maintenance of wakefulness and a multiplicity of other roles.
    Kilduff TS
    Sleep Med Rev; 2005 Aug; 9(4):227-30. PubMed ID: 15998593
    [No Abstract]   [Full Text] [Related]  

  • 14. Excitotoxic degeneration of hypothalamic orexin neurons in slice culture.
    Katsuki H; Akaike A
    Neurobiol Dis; 2004 Feb; 15(1):61-9. PubMed ID: 14751771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.
    Hungs M; Fan J; Lin L; Lin X; Maki RA; Mignot E
    Genome Res; 2001 Apr; 11(4):531-9. PubMed ID: 11282968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding.
    Sutcliffe JG; de Lecea L
    J Neurosci Res; 2000 Oct; 62(2):161-8. PubMed ID: 11020209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights.
    Ritchie C; Okuro M; Kanbayashi T; Nishino S
    Curr Neurol Neurosci Rep; 2010 May; 10(3):180-9. PubMed ID: 20425033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypothalamic peptidergic system, hypocretin/orexin and vigilance control.
    Nishino S
    Neuropeptides; 2007 Jun; 41(3):117-33. PubMed ID: 17376528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neurotransmitter, hypocretin. An overview].
    Baumann C; Bassetti C
    Nervenarzt; 2004 Apr; 75(4):317-23. PubMed ID: 15088087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in hypocretin/orexin pathway genes and narcolepsy.
    Olafsdóttir BR; Rye DB; Scammell TE; Matheson JK; Stefánsson K; Gulcher JR
    Neurology; 2001 Nov; 57(10):1896-9. PubMed ID: 11723285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.